Cas:785038-49-5 (3R)-3-amino-4-(3-chlorophenyl)butanoic acid manufacturer & supplier

Chemical Name:(3R)-3-amino-4-(3-chlorophenyl)butanoic acid

CAS.NO:785038-49-5

Synonyms:(3R)-3-amino-4-(3-chlorophenyl)butanoic acid

Molecular Formula:C₁₀H₁₂ClNO₂

Molecular Weight:213.66100

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:360.2ºC at 760 mmHg

Density:1.287g/cm3

Index of Refraction:1.577

PSA:63.32000

Exact Mass:213.05600

LogP:2.38480

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (3R)-3-amino-4-(3-chlorophenyl)butanoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(3R)-3-amino-4-(3-chlorophenyl)butanoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(3R)-3-amino-4-(3-chlorophenyl)butanoic acid Use and application,(3R)-3-amino-4-(3-chlorophenyl)butanoic acid technical grade,usp/ep/jp grade.

Related News: Last year, California became the first state in the country to ban toxic chemicals in cosmetics — including a number of PFAS. Maryland did the same this month, but the laws don’t take effect until 2025, the Post reported. (3R)-3-amino-4-(3-chlorophenyl)butanoic acid manufacturer Over the past twelve months, the collaboration team has worked to optimize its processes for making T cells from iPSCs, and has now shown the production of pure T-lymphocytes consisting of both CD8+ and CD4+ T cells having a global gene expression profile that is highly-similar to primary T cells based on a principal component analysis. (3R)-3-amino-4-(3-chlorophenyl)butanoic acid supplier Immediately thereafter, the iLet begins controlling blood-sugar levels automatically, without requiring the user to count carbohydrates, set insulin delivery rates, or deliver bolus insulin for meals or corrections. (3R)-3-amino-4-(3-chlorophenyl)butanoic acid vendor Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday. (3R)-3-amino-4-(3-chlorophenyl)butanoic acid factory Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.